iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Up 158.5% in July

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 7,895 shares, an increase of 158.5% from the July 15th total of 3,054 shares. Based on an average trading volume of 2,182 shares, the short-interest ratio is currently 3.6 days. Approximately 5.3% of the shares of the stock are sold short.

iShares Neuroscience and Healthcare ETF Price Performance

IBRN opened at $39.14 on Friday. The stock has a market cap of $5.87 million, a P/E ratio of 15.61 and a beta of 0.75. The stock’s 50 day simple moving average is $37.56 and its 200 day simple moving average is $34.79. iShares Neuroscience and Healthcare ETF has a 1-year low of $24.12 and a 1-year high of $43.01.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.